Skip to content

Clinical trials

Phase 1/2 Hepatitis C trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Phase: Phase 1/2 Country / region: United States Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20082
20091
20101
20113
20121
20132
20141
20211
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)3
Vertex Pharmaceuticals Incorporated2
Anza Therapeutics, Inc.1
Biolex Therapeutics, Inc.1
Bristol-Myers Squibb1
HanAll BioPharma Co., Ltd.1
Henry Sacks1
National Center for Complementary and Integrative Health (NCCIH)1
National Institutes of Health Clinical Center (CC)1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C16
Hepatitis C, Chronic3
HIV Infections2
Digestive System Diseases1
Flaviviridae Infections1
Hepatitis1
Hepatitis, Chronic1
RNA Virus Infections1
Virus Diseases1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.